Sym-Bio, an entrepreneurial Chinese diagnostics company with a product line tests for infectious diseases, has agreed PerkinElmer, an international company with businesses in neonatal testing, life science services, health and the environment to be acquired. Sym-Bio intends to accelerate its growth and competitive position in China through this strategic move, and PerkinElmer wants to expand its access to the Chinese market, take advantage of the cost benefits of operating in China, and tap int … Read more »

Sym-Bio, an entrepreneurial Chinese diagnostics company with a product line tests for infectious diseases, has agreed PerkinElmer, an international company with businesses in neonatal testing, life science services, health and the environment to be acquired. Sym-Bio intends to accelerate its growth and competitive position in China through this strategic move, and PerkinElmer wants to expand its access to the Chinese market, take advantage of the cost benefits of operating in China, and tap into the talent pool of young Chinese scientists. Strategic and operational integration of Sym-Bio in PerkinElmer is explored through the lens of the founder and CEO of Sym-Bio and the acquiring company.
To maximize their effectiveness, color cases should be printed in color.
«Hide

from
Vicki L. Sato,
Christoph Jäker,
Kareem Reda
Source: HBS
17 pages.
Release Date: 13 November 2011. Prod #: 612032-PDF-ENG
PerkinElmer – developing products in China for China HBR case solution

[related_post themes="flat"]